Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Difficulties in treating pregnant patients

Dr Vesna Kesic - University of Serbia, Belgrade
Difficulties in treating pregnant patients ( Dr Vesna Kesic - University of Serbia, Belgrade )
27 Apr 2012

Impact of treatment on pregnancy

Dr Hatem Azim - Institute Jules Bordet, Brussels, Belgium
Impact of treatment on pregnancy ( Dr Hatem Azim - Institute Jules Bordet, Brussels, Belgium )
27 Apr 2012

Rare and common cancers during pregnancy

Prof Nikolaos Pavlidis - University of Ioannina, Greece
Rare and common cancers during pregnancy ( Prof Nikolaos Pavlidis - University of Ioannina, Greece )
27 Apr 2012

Galeterone safe and effective against prostate cancer

Dr Bruce Montgomery - University of Washington, Seattle, USA
Galeterone safe and effective against prostate cancer ( Dr Bruce Montgomery - University of Washington, Seattle, USA )
13 Apr 2012

Chemothereapy with endocrine therapy and bisphosphonates in early breast cancer

Prof Michael Gnant - Medical University of Vienna, Austria
Chemothereapy with endocrine therapy and bisphosphonates in early breast cancer ( Prof Michael Gnant - Medical University of Vienna, Austria )
2 Apr 2012

Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond

Dr Evandro De Azambuja - Institut Jules Bordet, Brussels, Belgium
Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond ( Dr Evandro De Azambuja - Institut Jules Bordet, Brussels, Belgium )
2 Apr 2012

Non-drug treatments to help alleviate symptoms of treatment-induced menopause

Dr Marc van Beurden - Netherlands Cancer Institute, Amsterdam
Non-drug treatments to help alleviate symptoms of treatment-induced menopause ( Dr Marc van Beurden - Netherlands Cancer Institute, Amsterdam )
2 Apr 2012

Triple negative advanced breast cancer treatment with PARP inhibitors

Dr Tim Yap - Royal Marsden Hospital, London, UK
Triple negative advanced breast cancer treatment with PARP inhibitors ( Dr Tim Yap - Royal Marsden Hospital, London, UK )
30 Mar 2012

Managing the toxicity of aromatase inhibitors

Dr Patrick Neven - Leuven University, Belgium
Managing the toxicity of aromatase inhibitors ( Dr Patrick Neven - Leuven University, Belgium )
29 Mar 2012

Analysis of thirty years of clinical trial data

Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK
Analysis of thirty years of clinical trial data ( Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK )
23 Mar 2012

Intraperitoneal therapy: current questions

Prof Franco Muggia – New York University Medical Center, USA
Intraperitoneal therapy: current questions ( Prof Franco Muggia – New York University Medical Center, USA )
24 Nov 2011

PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast cancer

Dr Daniel Silver - Dana Farber Cancer Institute, Boston, Massachusetts, USA
PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast cancer ( Dr Daniel Silver - Dana Farber Cancer Institute, Boston, Massachusetts, USA )
24 Nov 2011